Why the study?
Conclusive evidence on Impella in AMI complicated by cardiogenic shock is lacking, but pre-PCI initiation has been suggested to improve survival.
Does pre-PCI Impella initiation reduce 30-day all-cause mortality in patients with acute myocardial infarction complicated by cardiogenic shock compared to post-PCI initiation?
Does pre-PCI Impella initiation reduce 30-day all-cause mortality in patients with acute myocardial infarction complicated by cardiogenic shock compared to post-PCI initiation?
In patients with AMI complicated by cardiogenic shock, initiating Impella before PCI did not significantly reduce 30-day all-cause mortality compared to post-PCI initiation, though it was associated with lower cardiac mortality.
No significant all-cause mortality difference; hypothesis-generating for pre-PCI Impella timing in STEMI shock, pending RCTs.
BACKGROUND: In selected patients with an acute myocardial infarction (AMI) complicated by Cardiogenic shock (CS), mechanical circulatory support with Impella may be beneficial, although conclusive evidence is still lacking. Nevertheless, it has been suggested that Impella initiation prior to primary PCI might improve survival. OBJECTIVE: To investigate the effect pre-PCI versus immediate post-PCI Impella initiation on short term mortality. METHODS: A prospective, single center, observational study, was performed including all patients with STEMI complicated by CS, treated with primary PCI and Impella. Thirty day mortality was compared between patients with Impella initiation pre-PCI and immediately post-PCI. RESULTS: A total of 88 patients were included. In the pre-PCI group (n = 21), admission heart rate was lower (84 versus 94 bpm, p = 0.04) and no IABP was implanted before Impella initiation, versus 17.9% in post-PCI group (n = 67), p = 0.04. Total 30-day all-cause mortality was 58%, and was lower in pre-PCI group, 47.6% versus 61.2% in the post-PCI group, however not statistically significant (HR 0.7, 95% CI 0.3-1.3, p = 0.21). Thirty-day cardiac mortality was significantly lower in the pre-PCI group, 19% versus 44.7% in the post-PCI group (HR 0.3, 95% CI 0.09-0.96, p = 0.042). CONCLUSION: Pre-PCI Impella initiation in AMICS patients was not associated with a statistically significant difference in 30-day all-cause mortality, compared to post-PCI Impella initiation.
No takes yet. Share an insight, caveat, or question.
Hemradj et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: